| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
40,010,000 |
| Market
Cap: |
925.03(M) |
| Last
Volume: |
1,008,943 |
Avg
Vol: |
1,006,166 |
| 52
Week Range: |
$12.64 - $30.11 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Cassava Sciences is a clinical-stage biotechnology company. Co. has combined technology with insights in neurobiology to develop solutions for Alzheimer's disease and other neurodegenerative diseases. Co. has two biopharmaceutical assets under development: its primary therapeutic product candidate, called simufilam, is a treatment for Alzheimer's disease; and its primary investigational diagnostic product candidate, called SavaDx, is a way to detect the existence of Alzheimer's disease from a small sample of blood.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
48,477 |
278,477 |
| Total Buy Value |
$0 |
$0 |
$831,428 |
$6,164,449 |
| Total People Bought |
0 |
0 |
2 |
4 |
| Total Buy Transactions |
0 |
0 |
3 |
9 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Friedmann Nadav |
Chief Operating Officer |
• • – |
2013-05-01 |
4 |
A |
$1.92 |
$12,493 |
D/D |
6,507 |
312,250 |
|
- |
|
| Barbier Remi |
CEO, Chairman of the Board |
• • • |
2012-12-31 |
5 |
GA |
$0.00 |
$0 |
I/I |
2,002,700 |
2,114,125 |
|
- |
|
| Barbier Remi |
CEO, Chairman of the Board |
• • • |
2012-12-31 |
5 |
GA |
$0.00 |
$0 |
I/I |
13,600 |
2,114,125 |
|
- |
|
| Barbier Remi |
CEO, Chairman of the Board |
• • • |
2012-12-31 |
5 |
GD |
$0.00 |
$0 |
D/D |
2,001,500 |
4,323,378 |
|
- |
|
| Barbier Remi |
CEO, Chairman of the Board |
• • • |
2012-12-31 |
5 |
GD |
$0.00 |
$0 |
D/D |
37,400 |
4,323,378 |
|
- |
|
| Barbier Remi |
CEO, Chairman of the Board |
• • • |
2012-12-05 |
4 |
OE |
$2.29 |
$8,091 |
I/I |
3,533 |
96,283 |
|
- |
|
| Roddy Peter S |
Chief Fiancial Officer |
• – – |
2012-11-01 |
4 |
A |
$2.51 |
$1,496 |
D/D |
596 |
81,948 |
|
- |
|
| Friedmann Nadav |
Chief Operating Officer |
• • – |
2012-11-01 |
4 |
A |
$2.51 |
$5,291 |
D/D |
2,108 |
330,743 |
|
- |
|
| Barbier Remi |
CEO, Chairman of the Board |
• • • |
2012-10-16 |
4 |
A |
$0.00 |
$0 |
I/I |
36,775 |
92,750 |
|
- |
|
| Barbier Remi |
CEO, Chairman of the Board |
• • • |
2012-10-16 |
4 |
A |
$0.00 |
$0 |
D/D |
110,325 |
6,103,378 |
|
- |
|
| Friedmann Nadav |
Chief Operating Officer |
• • – |
2012-10-16 |
4 |
A |
$0.00 |
$0 |
D/D |
55,162 |
328,635 |
|
- |
|
| Schoenhard Grant |
Chief Scientific Officer |
• – – |
2012-10-16 |
4 |
A |
$0.00 |
$0 |
D/D |
11,032 |
66,531 |
|
- |
|
| Roddy Peter S |
Chief Fnancial Officer |
• – – |
2012-10-16 |
4 |
A |
$0.00 |
$0 |
D/D |
11,032 |
81,352 |
|
- |
|
| Roddy Peter S |
Chief Financial Officer |
• – – |
2012-05-01 |
4 |
A |
$3.45 |
$14,998 |
D/D |
4,346 |
70,320 |
|
- |
|
| Barbier Remi |
CEO, Chairman of the Board |
• • • |
2011-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
5,993,053 |
|
- |
|
| Roddy Peter S |
Chief Financial Officer |
• – – |
2011-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
11,032 |
65,974 |
|
- |
|
| Friedmann Nadav |
Chief Operating Officer |
• • – |
2011-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
269,851 |
|
- |
|
| Friedmann Nadav |
Chief Operating Officer |
• • – |
2011-11-01 |
4 |
A |
$3.86 |
$2,300 |
D/D |
596 |
259,851 |
|
- |
|
| Roddy Peter S |
Chief Financial Officer |
• – – |
2011-11-01 |
4 |
A |
$3.86 |
$741 |
D/D |
192 |
54,942 |
|
- |
|
| Friedmann Nadav |
Chief Operating Officer |
• • – |
2011-10-18 |
4 |
S |
$4.44 |
$111,007 |
D/D |
(25,000) |
259,255 |
|
- |
|
| Perry Craig |
10% Owner |
– – • |
2011-10-04 |
4 |
S |
$4.50 |
$1,430,663 |
D/D |
(315,000) |
4,263,076 |
|
- |
|
| Friedmann Nadav |
Chief Operating Officer |
• • – |
2011-10-04 |
4 |
S |
$4.59 |
$32,118 |
D/D |
(7,000) |
284,255 |
|
- |
|
| Perry Craig |
10% Owner |
– – • |
2011-10-03 |
4 |
S |
$4.83 |
$323,409 |
D/D |
(67,000) |
4,578,076 |
|
- |
|
| Friedmann Nadav |
Chief Operating Officer |
• • – |
2011-10-03 |
4 |
S |
$4.89 |
$39,122 |
D/D |
(8,000) |
291,255 |
|
- |
|
| Friedmann Nadav |
Chief Operating Officer |
• • – |
2011-09-30 |
4 |
S |
$4.91 |
$49,060 |
D/D |
(10,000) |
299,255 |
|
- |
|
504 Records found
|
|
Page 5 of 21 |
|
|
1.56 (7.24%) 
